Methylation assay by nucleotide incorporation: a quantitative assay for regional CpG methylation density

被引:6
作者
Yamamoto, T
Nagasaka, T
Notohara, K
Sasamoto, H
Murakami, J
Tanaka, N
Matsubara, N
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Gastroenterol Surg & Surg Oncol, Okayama 7008558, Japan
[2] Int Reagents Corp, Kobe, Hyogo, Japan
[3] Sysmex Corp, Kobe, Hyogo, Japan
关键词
D O I
10.2144/04365RR02
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Although the aberrant methylation in CpG islands is of great interest as a causative role in human malignancies, it has been very difficult to accurately determine methylation density. Here we report a novel microplate-based quantitative methylation assay, designated MANIC, for a region containing a number of CpG sites based on incorporation of hapten-labeled dCTP at cytosine sites where the methylated cytosines have not been converted to uracil try the bisulfite treatment. Validation using control DNAs revealed that the method was sensitive enough to detect <1.25% methylated DNA and that calibration curve was linear. With this approach, we determined relative methylation density. of O-6-methylguanine-DNA methyltranferase gene promoter containing 12 CpG sites among the 12 colorectal cancers and corresponding normal Inucosal tissues. Consequently, MANIC showed a high concordance with results by a quantitative method, bisulfite PCR single-stranded conformational polymorphism (BiPS). MANIC is a technique that avoids cumbersome procedures such as electrophoresis or the use of radiolabeling and is applicable to any sequence regardless of the total number of CpG sites or heterogeneity in methylation status.
引用
收藏
页码:846 / +
页数:7
相关论文
共 25 条
[1]  
CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
[2]   MethyLight: a high-throughput assay to measure DNA methylation [J].
Eads, Cindy A. ;
Danenberg, Kathleen D. ;
Kawakami, Kazuyuki ;
Saltz, Leonard B. ;
Blake, Corey ;
Shibata, Darryl ;
Danenberg, Peter V. ;
Laird, Peter W. .
NUCLEIC ACIDS RESEARCH, 2000, 28 (08) :32
[3]   A rapid, quantitative, non-radioactive bisulfite-SNuPE-IP RP HPLC assay for methylation analysis at specific CpG sites [J].
El-Maarri, O ;
Herbiniaux, U ;
Walter, J ;
Oldenburg, J .
NUCLEIC ACIDS RESEARCH, 2002, 30 (06) :25
[4]  
Esteller M, 1999, CANCER RES, V59, P793
[5]   Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents [J].
Esteller, M ;
Garcia-Foncillas, J ;
Andion, E ;
Goodman, SN ;
Hidalgo, OF ;
Vanaclocha, V ;
Baylin, SB ;
Herman, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (19) :1350-1354
[6]  
Esteller M, 2001, CANCER RES, V61, P3225
[7]   A GENOMIC SEQUENCING PROTOCOL THAT YIELDS A POSITIVE DISPLAY OF 5-METHYLCYTOSINE RESIDUES IN INDIVIDUAL DNA STRANDS [J].
FROMMER, M ;
MCDONALD, LE ;
MILLAR, DS ;
COLLIS, CM ;
WATT, F ;
GRIGG, GW ;
MOLLOY, PL ;
PAUL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1827-1831
[8]  
Futscher B W, 1989, Cancer Commun, V1, P65
[9]   Enzymatic regional methylation assay: A novel method to quantify regional CpG methylation density [J].
Galm, O ;
Rountree, MR ;
Bachman, KE ;
Jair, KW ;
Baylin, SB ;
Herman, JG .
GENOME RESEARCH, 2002, 12 (01) :153-157
[10]  
GERSON SL, 1989, CANCER RES, V49, P3134